Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01037088 · ClinicalTrials.gov registry record · Phase 1
Effects of Vaporized Marijuana on Neuropathic Pain
A Phase 1 study, sponsored by University of California, Davis.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
NCT01037088 is a Phase 1 study that has completed, run by University of California, Davis. The registered enrollment target is 44 participants.
The verdict
NCT01037088, a Phase 1 study, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study theorized that a low dose of vaporized cannabis could alleviate nerve injury pain.
Interventions
- DRUG Cannabis
- DRUG Mild dose cannabis
- DRUG Low dose cannabis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01037088
The ClinicalTrials.gov registry entry for NCT01037088 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Davis, which has 657 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cannabis is the first listed.
NCT01037088 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01037088 about?
NCT01037088 is a clinical study titled "Effects of Vaporized Marijuana on Neuropathic Pain". This study theorized that a low dose of vaporized cannabis could alleviate nerve injury pain.
What is the current status of trial NCT01037088?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2009-12. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01037088?
The interventions under investigation include: Cannabis (DRUG), Mild dose cannabis (DRUG), Low dose cannabis (DRUG).
Who is sponsoring clinical trial NCT01037088?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.